Concepedia

ABB (Japan)

A(

196

Publications

5.4K

Citations

16

Authors

Tokyo

Japan

Other names

ASEA Brown Boveri

ABB (Japan) is a company institution in Tokyo, Japan known for medicine, pharmacotherapy, and pharmacology.

HomepageWikipediaROR

Top concepts

Publications

196

Discontinuation of adalimumab after achieving remission in patients with established rheumatoid arthritis: 1-year outcome of the HONOR study

Yoshiya Tanaka, Shintaro Hirata, Satoshi Kubo et al. · Annals of the Rheumatic Diseases · 2013 · 187 citations · Full text

Safety and effectiveness of adalimumab in Japanese rheumatoid arthritis patients: Postmarketing surveillance report of 7740 patients

Takao Koike, Masayoshi Harigai, Naoki Ishiguro et al. · Modern Rheumatology · 2013 · 161 citations

Efficacy and safety of risankizumab in Japanese patients with moderate to severe plaque psoriasis: Results from the Susta<scp>IMM</scp> phase 2/3 trial

Mamitaro Ohtsuki, Hideki Fujita, Keiko Suzaki et al. · The Journal of Dermatology · 2019 · 92 citations · Full text

Targeting Kynurenine Aminotransferase II in Psychiatric Diseases: Promising Effects of an Orally Active Enzyme Inhibitor

Haitao Wu, M Okuyama, Yasushi Kajii et al. · Schizophrenia Bulletin · 2014 · 76 citations · Full text

Economic Burden of Parkinson’s Disease: A Multinational, Real-World, Cost-of-Illness Study

К. Ray Chaudhuri, Jean‐Philippe Azulay, Per Odin et al. · Drugs - Real World Outcomes · 2024 · 74 citations · Full text

Rows per page

1–5 of 196

Authors

16

PublicationsCitationsH-Index
SK
Susumu Kitamura

ABB (Japan)

9

3.6K

7

NM
Naoto Matsuda

ABB (Japan)

19

155

5

TK
Tomoko Kashiwagi

ABB (Japan)

6

66

5

KI
Kanako Ishii

ABB (Japan)

8

83

5

HH
Hideyuki Hashiba

ABB (Japan)

8

101

5

Rows per page

1–5 of 16